Left ventricular pacing in the treatment of pediatric cardiac dysfunction caused by idiopathic complete left bundle

Xiaomei Li1,2, Jinghao Li1,2, Yongqiang Jin1

  • 1Department of Pediatric Cardiology, Heart Center, the First Hospital of Tsinghua University (Beijing Huaxin Hospital), Beijing, China.

Insights

Transthoracic epicardial dual-chamber pacemaker implantation effectively treats cardiac dysfunction in children with idiopathic complete left bundle branch block (CLBBB). This procedure restores normal cardiac function and synchrony, offering a viable treatment option.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Electrophysiology
  • Medical Device Technology

Background:

  • Idiopathic complete left bundle branch block (CLBBB) can lead to significant cardiac dysfunction in children.
  • Current treatment options for pediatric CLBBB-induced cardiac dysfunction are limited.
  • Epicardial pacemaker implantation is a potential therapeutic strategy.

Purpose of the Study:

  • To assess the feasibility and effectiveness of transthoracic epicardial dual-chamber pacemaker implantation.
  • To evaluate the impact of this intervention on cardiac function and synchrony in pediatric patients with CLBBB.
  • To determine the long-term outcomes of this treatment modality.

Main Methods:

  • A cohort of nine children with cardiac dysfunction due to idiopathic CLBBB underwent transthoracic epicardial dual-chamber pacemaker implantation.
  • Cardiac function was assessed using echocardiography.
  • Intraventricular synchronization was evaluated with two-dimensional speckle tracking echocardiography (STE).

Main Results:

  • All nine patients experienced normalization of cardiac function within one year post-implantation.
  • Postoperative QRS duration significantly decreased compared to baseline.
  • Preoperative cardiac dyssynchrony was completely corrected, with significant improvements in STE-derived synchronization parameters.

Conclusions:

  • Transthoracic epicardial dual-chamber pacemaker implantation is a feasible and effective treatment for children with cardiac dysfunction caused by idiopathic CLBBB.
  • The procedure leads to significant improvements in cardiac function and intraventricular synchrony.
  • This approach offers a promising therapeutic option for this pediatric population.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
17
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
73
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
28
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
9.5K